A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Remibrutinib Impurity 46 - Request Quote

Picture of Remibrutinib Impurity 46

Remibrutinib Impurity 46

SZ CAT No:SZ-R098050
CAS No
NA
Mol.F.
C12H21N5O3
Mol.Wt.
283.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Remibrutinib Impurity 46 is chemically Tert-butyl (2-((4,6-diaminopyrimidin-5-yl)oxy)ethyl)(methyl)carbamate. Remibrutinib Impurity 46 is supplied with detailed characterization data compliant with regulatory guideline. Remibrutinib Impurity 46 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Remibrutinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Remibrutinib Impurity 46

Purchase Remibrutinib Impurity 46

Remibrutinib Impurity 46 suppliers

Remibrutinib Impurity 46 manufacturers

Remibrutinib Impurity 46 price

Order Remibrutinib Impurity 46

Enquire Remibrutinib Impurity 46

Remibrutinib Impurity 46 cost

Remibrutinib Impurity 46 Supplier

Remibrutinib Impurity 46 Distributor

Remibrutinib Impurity 46 for Method Validation

Remibrutinib Reference Standard

Remibrutinib Impurity 46 for ANDA Filing

Remibrutinib Impurity 46 for Forced Degradation Studies

Remibrutinib Impurity 46 Identification Standards

Remibrutinib Impurity 46 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,